TY - JOUR
T1 - Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015
T2 - Magnitude, temporal trends and projections
AU - Bourne, Rupert R.A.
AU - Jonas, Jost B.
AU - Bron, Alain M.
AU - Cicinelli, Maria Vittoria
AU - Das, Aditi
AU - Flaxman, Seth R.
AU - Friedman, David S.
AU - Keeffe, Jill E.
AU - Kempen, John H.
AU - Leasher, Janet
AU - Limburg, Hans
AU - Naidoo, Kovin
AU - Pesudovs, Konrad
AU - Peto, Tunde
AU - Saadine, Jinan
AU - Silvester, Alexander J.
AU - Tahhan, Nina
AU - Taylor, Hugh R.
AU - Varma, Rohit
AU - Wong, Tien Y.
AU - Resnikoff, Serge
N1 - Funding Information:
1Vision & Eye Research Unit, Anglia Ruskin University, Cambridge, UK 2Department of Ophthalmology, Universitätsmedizin, Mannheim, Germany 3Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany 4INRA, UMR1324 Centre des Sciences du Goût et de l’Alimentation, Dijon, France 5CNRS, UMR6265 Centre des Sciences du Goût et de l’Alimentation, Dijon, France 6Centre des Sciences du Goût et de l’Alimentation, Université Bourgogne Franche-Comté, Dijon, France 7Ophthalmology Department, Dijon University Hospital, Dijon, France 8San Raffaele Scientific Institute, Milan, Italy 9Health Education Yorkshire and the Humber, Leeds, UK 10Department of Mathematics and Data Science Institute, Imperial College London, London, UK 11Department of Statistics, University of Oxford, Oxford, UK 12Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 13LV Prasad Eye Institute, Hyderabad, India 14Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA 15Discovery Eye Center, Addis Ababa, Ethiopia 16Myungsung Christian Medical Center and Medical School, Addis Ababa, Ethiopia 17Nova Southeastern University, Davie, Florida, USA 18Health Information Services, Grootebroek, The Netherlands 19African Vision Research Institute, University of Kwazulu-Natal, Brien Holden Vision Institute, Durban, South Africa 20NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, South Australia, Australia 21School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK 22Centers for Disease Control and Prevention, Atlanta, Georgia, USA 23St Pauls Eye Unit, Royal Liverpool University Hospital, Liverpool, UK 24Brien Holden Vision Institute, Sydney, New South Wales, Australia 25School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia 26Melbourne School of Population Health, University of Melbourne, Melbourne, Victoria, Australia 27Department of Ophthalmology, Keck School of Medicine of USC, Los Angeles, California, USA 28Singapore Eye Research Institute, Duke-NUS Graduate Medical School, National University of Singapore, Singapore
Publisher Copyright:
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Background Within a surveillance of the prevalence and causes of vision impairment in high-income regions and Central/Eastern Europe, we update figures through 2015 and forecast expected values in 2020. Methods Based on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment and presbyopia was estimated for 1990, 2010, 2015, and 2020. Results Age-standardised prevalence of blindness and MSVI for all ages decreased from 1990 to 2015 from 0.26% (0.10-0.46) to 0.15% (0.06-0.26) and from 1.74% (0.76-2.94) to 1.27% (0.55-2.17), respectively. In 2015, the number of individuals affected by blindness, MSVI and mild vision impairment ranged from 70 000, 630 000 and 610 000, respectively, in Australasia to 980 000, 7.46 million and 7.25 million, respectively, in North America and 1.16 million, 9.61 million and 9.47 million, respectively, in Western Europe. In 2015, cataract was the most common cause for blindness, followed by age-related macular degeneration (AMD), glaucoma, uncorrected refractive error, diabetic retinopathy and cornea-related disorders, with declining burden from cataract and AMD over time. Uncorrected refractive error was the leading cause of MSVI. Conclusions While continuing to advance control of cataract and AMD as the leading causes of blindness remains a high priority, overcoming barriers to uptake of refractive error services would address approximately half of the MSVI burden. New data on burden of presbyopia identify this entity as an important public health problem in this population. Additional research on better treatments, better implementation with existing tools and ongoing surveillance of the problem is needed.
AB - Background Within a surveillance of the prevalence and causes of vision impairment in high-income regions and Central/Eastern Europe, we update figures through 2015 and forecast expected values in 2020. Methods Based on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment and presbyopia was estimated for 1990, 2010, 2015, and 2020. Results Age-standardised prevalence of blindness and MSVI for all ages decreased from 1990 to 2015 from 0.26% (0.10-0.46) to 0.15% (0.06-0.26) and from 1.74% (0.76-2.94) to 1.27% (0.55-2.17), respectively. In 2015, the number of individuals affected by blindness, MSVI and mild vision impairment ranged from 70 000, 630 000 and 610 000, respectively, in Australasia to 980 000, 7.46 million and 7.25 million, respectively, in North America and 1.16 million, 9.61 million and 9.47 million, respectively, in Western Europe. In 2015, cataract was the most common cause for blindness, followed by age-related macular degeneration (AMD), glaucoma, uncorrected refractive error, diabetic retinopathy and cornea-related disorders, with declining burden from cataract and AMD over time. Uncorrected refractive error was the leading cause of MSVI. Conclusions While continuing to advance control of cataract and AMD as the leading causes of blindness remains a high priority, overcoming barriers to uptake of refractive error services would address approximately half of the MSVI burden. New data on burden of presbyopia identify this entity as an important public health problem in this population. Additional research on better treatments, better implementation with existing tools and ongoing surveillance of the problem is needed.
KW - epidemiology
KW - glaucoma
KW - public health
UR - http://www.scopus.com/inward/record.url?scp=85046352593&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046352593&partnerID=8YFLogxK
U2 - 10.1136/bjophthalmol-2017-311258
DO - 10.1136/bjophthalmol-2017-311258
M3 - Article
C2 - 29545417
AN - SCOPUS:85046352593
VL - 102
SP - 575
EP - 585
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
SN - 0007-1161
IS - 5
ER -